Why Women Choose At-Home Abortion via Teleconsultation in France?: A Mixed-Method Study on Drivers of Telemedicine Abortion

Objectives: In face of the COVID-19 health emergency, France has allowed medical abortions to be performed by teleconsultation until 9 weeks of gestation. In an attempt to understand the demand and main drivers of telemedicine abortion, we analysed the requests that Women on Web (WoW), an online telemedicine abortion service operating worldwide, received from France throughout 2020. Methods: We conducted a parallel convergent mixed-method study among 809 consultations received from France at WoW between 1 January and 31 December 2020. We performed a cross-sectional study of data obtained from the WoW consultation survey and a manifest content analysis of anonymised email correspondence of 140 women consulting with WoW helpdesk from France. Results: We found that women encounter macro-level, individual-level, and provider-level constraints while trying to access abortion in France. The preferences and needs over secrecy (46.2%), privacy (38.3%), and comfort (34.9%) are among the most frequent reasons for women from France to choose telemedicine abortion through WoW. The COVID-19 pandemic seems to be an important driver for resorting to telemedicine (30.6%). The lockdowns seem to have had an impact on the number of consultations received at WoW from France, increasing from 60 in March to 128 in April during the first lockdown and from 54 in October to 80 in November during the second lockdown. Conclusions: The demand for at-home medical abortion via teleconsultation increased in France during the lockdowns. However, drivers of telemedicine abortion are multi-dimensional and go beyond the conditions unique to the pandemic. Given the various constraints women continue to encounter in accessing safe abortion, telemedicine can help meet womens preferences and needs for secrecy, privacy and comfort, while facilitating improved access to and enabling more person-centred abortion care.

[1]  P. Lohr,et al.  Effectiveness, safety and acceptability of no‐test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study , 2021, BJOG : an international journal of obstetrics and gynaecology.

[2]  A. Agostini,et al.  COVID-19 impact in abortions’ practice, a regional French evaluation , 2020, Journal of Gynecology Obstetrics and Human Reproduction.

[3]  C. Aiken,et al.  Demand for self-managed online telemedicine abortion in eight European countries during the COVID-19 pandemic: a regression discontinuity analysis , 2020, BMJ Sexual & Reproductive Health.

[4]  Rishita Nandagiri,et al.  COVID-19 and Abortion: Making Structural Violence Visible. , 2020, International perspectives on sexual and reproductive health.

[5]  P. Lohr,et al.  Effectiveness, safety and acceptability of no-test medical abortion provided via telemedicine: a national cohort study , 2020, medRxiv.

[6]  K. Gemzell‐Danielsson,et al.  Abortion regulation in Europe in the era of COVID-19: a spectrum of policy responses , 2020, BMJ Sexual & Reproductive Health.

[7]  Sophie Günther,et al.  Why women choose abortion through telemedicine outside the formal health sector in Germany: a mixed-methods study , 2020, BMJ Sexual & Reproductive Health.

[8]  C. Aiken,et al.  Demand for Self-Managed Online Telemedicine Abortion in the United States During the Coronavirus Disease 2019 (COVID-19) Pandemic , 2020, Obstetrics and gynecology.

[9]  D. Grossman Telemedicine for medical abortion – time to move towards broad implementation , 2019, BJOG : an international journal of obstetrics and gynaecology.

[10]  Lotsa Web Team Nora's Stars - Terms of Use and Privacy Policy , 2017 .

[11]  D. Grossman,et al.  Sixteen Years of Overregulation: Time to Unburden Mifeprex. , 2017, The New England journal of medicine.

[12]  G. Kleiverda,et al.  Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services , 2008, BJOG : an international journal of obstetrics and gynaecology.

[13]  J. Bouyer,et al.  Access to health care for induced abortions: analysis by means of a French national survey. , 2004, European journal of public health.

[14]  Michael P. Grady Qualitative and Action Research: A Practitioner Handbook , 1998 .